• Misconduct in Chinese Trials, Outcomes for BMS, Pfizer

    In the Pipeline | Bloomberg is reporting that a Bristol-Myers Squibb and Pfizer product approved last year was slowed by misconduct in its Chinese clinical trials.

    Jul 12, 2013
  • Smartphones in Clinical Trials: Notes from DIA

    CIO Australia | There's a wealth of technology available for use in clinical trials, and smartphones in particular offer a range of options.

    Jul 11, 2013
  • Comprehend's $8.4 Million for Clinical Dashboards

    Clinical Informatics News Brief | In May, Comprehend Systems opened online signup to users to create customized, interactive dashboards that extend across all of the systems that house clinical trial data. The company today announced $8.4 million in Series A financing from Sequoia Capital.

    Jul 11, 2013
  • Alzheimer’s Test Only Covered in Clinical Trials

    Medical Daily | Medicare and Medicaid have placed regulations on Eli Lilly's Amyvid test for Alzheimer's disease, only allowing coverage to patients who participate in clinical trials for the test.

    Jul 11, 2013
  • RWJF Study Finds Health-IT Increasing

    Health-IT News | The Robert Wood Johnson Foundation has released a new study finding that adoption levels of health-IT are increasing from small physician practices to academic medical centers.

    Jul 9, 2013
  • Open Source Data Creates Health-IT Companies

    Computerworld | The Obama administration says that its Data.gov open source initiative, started in 2009, is creating  jobs and spawning start-ups, including many health-IT companies. 

    Jul 9, 2013
  • Nicotine Vaccine in Development

    Nanowerk | A new project out of Arizona State University's Biodesign Institute is attempting to create a vaccine for nicotine dependence.

    Jul 3, 2013
  • Silver for Antibiotics

    Nature | Silver has a history of fighting infections with its antimicrobial properties, but exactly how it was done, or exactly what it’s properties were, have been unclear until recently. Biomedical engineer James Collins and his team at Boston University found that silver attacks bacterial cells by making the cell membrane more permeable and interfering with the cell’s metabolism.

    Jul 1, 2013
  • Bio-Innovation: Reinventing the R&D Business Model

    Clinical Informatics News | In an industry that spends billions of dollars each year on development, it’s surprising to hear conversations about the lack of innovation. Yet it is a troubling refrain in the pharmaceutical R&D landscape, claimed experts at Drug Information Association panel last week* led by Kenneth Getz, director of sponsored research at Tufts Center for the Study of Drug Development.

    Jul 1, 2013
  • DIA 2013: News and Products

    Clinical Informatics News | The Drug Information Association’s annual meeting is always a flurry of announcements and new products and this year is no different. Here is a roundup of some of the news briefs and products that have been announced this week in Boston.

    Jun 28, 2013
  • EMC Acquires Sitrof Technologies

    CMS Wire | EMC has acquired Sitrof Technologies, a document management consultancy, to meet demand for EMC's Information Intelligence Group's new Life Sciences solutions.

    Jun 27, 2013
  • Healthcare According to Tech

    Forbes | Healthcare needs technologists, the technologists say. And several wealthy investors are setting out to offer their own brand of salvation to the healthcare system

    Jun 24, 2013
  • May-June 2013 News Briefs

    Clinical Informatics News | News and products from around the clinical and health-IT industry including an EHR for psychiatrists, the results of an 8-country health-IT survey, an analytics platform for health care, and more.

    Jun 21, 2013
  • Pipeline Progress: Predicting Drug Approvals at Every Phase

    Clinical Informatics News | Infinata’s BioPharm Insight discovered a “revolutionary” new use for its massive drugs and clinical trials database after its consultants last summer probed the data for a contract research organization (CRO) wanting to better gauge resource needs around the future portfolio makeup of a key account, says Infinata Marketing Director Kris Sarajian.

    Jun 21, 2013
  • Five Keys to Drug Reimbursement

    Clinical Informatics News | Getting an FDA stamp of approval is not sufficient to ensure a drug will do well on the market. The onus is on drug makers to ensure their drug is priced well and paid for, even while it’s still in the development stage. I’ve identified five steps used by drug manufacturers to ensure reimbursement:

    Jun 20, 2013
  • PatientsLikeMe, inVentiv Health Enter Patient Recruitment Partnership

    Clinical Informatics News Brief | PatientsLikeMe and inVentiv Health are partnering to more quickly connect patients to clinical trials. PatientsLikeMe has 200,000 members who share information and experiences on more than 1,500 different diseases and conditions. These members—already interested in the development of new treatments—will be able to access information on clinical trials conducted by inVentiv’s pharmaceutical customers.

    Jun 17, 2013
  • Supreme Court on Pay-to-Delay

    Forbes | The Supreme Court has ruled against pay-to-delay deals, but wasn't fully clear on which kinds of deals are off the table.

    Jun 17, 2013
  • Surgeon General to Step Down

    Healthcare IT News | The Surgeon General of the United States, Regina Benjamin, has announced her plans to step down in July.

    Jun 14, 2013
  • Insightful Site Selection: Tools of the Trade

    Clinical Informatics News | As clinical trial site feasibility assessments proved less fruitful than futile, software solutions emerged to add efficiency and visibility to the matchup process between trial and site. The tools are making feasibility surveys more targeted sends and, in some cases, eliminating the questionnaires entirely. Effortlessly identifying the best sites and investigators and more reliably predicting trial enrollment success is the common end game.

    Jun 12, 2013
  • Randy Scott on Building a Clinical Genomics A-Team

    Clinical Informatics News | Randy Scott, Chairman and CEO of InVitae will be giving the plenary keynote at for TCGC: The Clinical Genome Conference on June 25, 2013 in San Francisco, Calif. In advance of his keynote, Bio-IT World’s former editor, Kevin Davies, chatted with Scott about building a clinical genomics A-team, the advantages of large gene panels, the rationale behind a targeted sequencing strategy, its relevance to routine medical practice today and more.

    Jun 11, 2013